Bo Ma
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Melanoma and MAPK Pathways 5
- RNA modifications and cancer 5
- Oncology 25
- Cancer Cells and Metastasis 11
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Alan Wells (16 shared papers)Amanda M. Clark (9 shared papers)Lushun Yuan (5 shared papers)Ye Tian (5 shared papers)Rui Cao (5 shared papers)Gang Wang (5 shared papers)Sarah Wheeler (3 shared papers)Jelena Grahovac (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Clinical & Translational Oncology (3 papers)International Journal of Oncology (2 papers)Journal of Cellular and Molecular Medicine (2 papers)British Journal of Cancer (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Bo Ma
81 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 110
- Cancer Research 554
- Oncology 772
- Pulmonary and Respiratory Medicine 551
- Parasitology 113
- Molecular Biology 1.0k
Countries citing papers authored by Bo Ma
This map shows the geographic impact of Bo Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ma more than expected).
Fields of papers citing papers by Bo Ma
This network shows the impact of papers produced by Bo Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ma. The network helps show where Bo Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 336 | |
| 2 | 2013 | 168 | |
| 3 | 2019 | 139 | |
| 4 | 2013 | 134 | |
| 5 | 1992 | 119 | |
| 6 | 2016 | 104 | |
| 7 | 2013 | 76 | |
| 8 | 2018 | 75 | |
| 9 | 2014 | 75 | |
| 10 | 2020 | 74 | |
| 11 | 2017 | 72 | |
| 12 | 2016 | 65 | |
| 13 | 2015 | 62 | |
| 14 | 2012 | 46 | |
| 15 | 2020 | 39 | |
| 16 | 2014 | 38 | |
| 17 | 2019 | 36 | |
| 18 | 2016 | 31 | |
| 19 | 2017 | 30 | |
| 20 | 2020 | 28 |
About Bo Ma
Bo Ma is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 86 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (11 papers), Cancer Immunotherapy and Biomarkers (7 papers), Cancer-related molecular mechanisms research (6 papers), Bladder and Urothelial Cancer Treatments (5 papers), Melanoma and MAPK Pathways (5 papers), Ferroptosis and cancer prognosis (5 papers), RNA modifications and cancer (5 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Cancer Research (554 citations), Oncology (772 citations), Pulmonary and Respiratory Medicine (551 citations), Parasitology (113 citations) and Molecular Biology (1.0k citations). Bo Ma has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Alan Wells, Amanda M. Clark, Lushun Yuan, Ye Tian, Rui Cao, Gang Wang, Sarah Wheeler, Jelena Grahovac, Douglas A. Lauffenburger and Carmen Vigo‐Pelfrey. Their work appears in journals such as Journal of Clinical Oncology, Clinical & Translational Oncology, International Journal of Oncology, Journal of Cellular and Molecular Medicine and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.